Burjeel Holdings sukuk priced at $500m as book oversubscribes 3.2x
Burjeel Holdings sukuk priced at $500m due 2031, yielding 7.125% after a $1.6bn book. Proceeds will refinance debt and fund clinical care, research and AI healthcare.
Burjeel Holdings has priced its inaugural unsecured senior sukuk in US dollars, marking a major step for the Abu Dhabi-listed healthcare group as it seeks deeper access to international capital markets. The $500 million issuance, due in 2031 and issued under a $1.5 billion Regulation S program, attracted strong demand that allowed the company to secure tighter pricing than initially guided. Net proceeds will be used to refinance existing indebtedness and to underwrite strategic investments across the group’s clinical and research agenda.
Burjeel prices $500 million Regulation S sukuk due 2031
The sukuk were priced with a profit rate of 7.000% and an effective yield of 7.125% to investors, reflecting improved terms from the company’s initial mid‑7% guidance. The transaction was structured under a Regulation S program and represents Burjeel’s first offering of unsecured senior sukuk in the international markets. Settlement and customary closing conditions remain in place ahead of the planned listing on London’s International Securities Market.
Oversubscription drove tighter pricing
Investor appetite pushed the order book to approximately $1.6 billion, about 3.2 times the size of the paper on offer. That strong subscription allowed Burjeel to improve pricing materially from initial indications and achieve what the company described as a notable outcome for an unrated private issuer from the Gulf region. Market participants noted the deal stands out as one of the lowest five‑year yields for a privately held, unrated GCC healthcare issuer in recent years.
Global investor demand and geographic allocation
International investors accounted for 61% of final allocations, underscoring global interest in the offering and in UAE healthcare credits. Investors from the United Kingdom received 34% of the allocation, while US offshore investors were allocated 24%. Regional participation remained robust, with Gulf investors taking 39% of the issuance, signalling continued confidence among local institutional buyers in the emirate’s capital markets and healthcare sector.
Proceeds earmarked for refinancing and strategic growth
According to the offering documents, net proceeds will be applied primarily to refinance existing debt and to support Burjeel’s strategic priorities. The group plans to channel funds toward expanding clinical services, advancing medical research, strengthening medical education and investing in innovation, including AI‑enabled healthcare solutions. Company executives have framed the funding as a means to enhance long‑term capital structure flexibility while accelerating clinical and technological initiatives.
Banks, syndication and planned London listing
Citi, Emirates NBD Capital and First Abu Dhabi Bank acted as joint global coordinators on the transaction and led the international syndication. Emirates NBD Capital and First Abu Dhabi Bank also served as sukuk structuring agents. The deal’s joint lead managers and bookrunners included Abu Dhabi Commercial Bank, Abu Dhabi Islamic Bank, Dubai Islamic Bank, RAKBANK and Sharjah Islamic Bank. The sukuk are expected to be admitted to trading on the London Stock Exchange’s International Securities Market once standard closing conditions are satisfied.
Transaction significance for UAE healthcare and capital markets
The successful placement highlights growing investor confidence in UAE‑based healthcare platforms and demonstrates the ability of regional healthcare groups to tap global liquidity on competitive terms. For Burjeel, the deal provides a tool to manage leverage and to finance expansion without diluting equity, while also raising the group’s international profile among fixed‑income investors. Market analysts view the transaction as a constructive signal for other Gulf healthcare issuers considering cross‑border debt capital solutions.
The issuance also reinforces Abu Dhabi’s role as a regional hub for healthcare investment and corporate finance, as local banks and international syndicates collaborated to bring the deal to market. By combining significant international allocations with strong regional participation, the sukuk underscores the appeal of UAE credits to a diverse investor base and may encourage further cross‑border issuance from the sector.